These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 28219426

  • 1. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.
    McCafferty S, Harris A, Kew C, Kassm T, Lane L, Levine J, Raven M.
    BMC Ophthalmol; 2017 Feb 20; 17(1):16. PubMed ID: 28219426
    [Abstract] [Full Text] [Related]

  • 2. Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac.
    Sengupta S, Vasavada D, Pan U, Sindal M.
    Indian J Ophthalmol; 2018 Jun 20; 66(6):827-830. PubMed ID: 29785993
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
    Campa C, Salsini G, Perri P.
    Curr Eye Res; 2018 Mar 20; 43(3):362-367. PubMed ID: 29120255
    [Abstract] [Full Text] [Related]

  • 4. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
    Miyake K, Ota I, Miyake G, Numaga J.
    J Cataract Refract Surg; 2011 Sep 20; 37(9):1581-8. PubMed ID: 21855758
    [Abstract] [Full Text] [Related]

  • 5. Preexisting epiretinal membrane is associated with pseudophakic cystoid macular edema.
    Schaub F, Adler W, Enders P, Koenig MC, Koch KR, Cursiefen C, Kirchhof B, Heindl LM.
    Graefes Arch Clin Exp Ophthalmol; 2018 May 20; 256(5):909-917. PubMed ID: 29564551
    [Abstract] [Full Text] [Related]

  • 6. Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared.
    Ylinen P, Taipale C, Lindholm JM, Laine I, Holmström E, Tuuminen R.
    Acta Ophthalmol; 2018 Dec 20; 96(8):853-859. PubMed ID: 30284393
    [Abstract] [Full Text] [Related]

  • 7. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
    Warren KA, Fox JE.
    Retina; 2008 Dec 20; 28(10):1427-34. PubMed ID: 18664937
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
    Almeida DR, Khan Z, Xing L, Bakar SN, Rahim K, Urton T, El-Defrawy SR.
    J Cataract Refract Surg; 2012 Sep 20; 38(9):1537-43. PubMed ID: 22795976
    [Abstract] [Full Text] [Related]

  • 9. Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.
    Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ.
    Ophthalmology; 2017 Jun 20; 124(6):776-785. PubMed ID: 28268098
    [Abstract] [Full Text] [Related]

  • 10. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.
    Tzelikis PF, Morato CS, Neves NT, Hida WT, Alves MR.
    J Cataract Refract Surg; 2018 Apr 20; 44(4):440-446. PubMed ID: 29685777
    [Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome - NSAID Is Needed.
    Ilveskoski L, Taipale C, Tuuminen R.
    Curr Eye Res; 2020 Jul 20; 45(7):814-819. PubMed ID: 31801388
    [Abstract] [Full Text] [Related]

  • 12. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF, Vieira M, Hida WT, Motta AF, Nakano CT, Nakano EM, Alves MR.
    Br J Ophthalmol; 2015 May 20; 99(5):654-8. PubMed ID: 25385061
    [Abstract] [Full Text] [Related]

  • 13. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
    Wolf EJ, Braunstein A, Shih C, Braunstein RE.
    J Cataract Refract Surg; 2007 Sep 20; 33(9):1546-9. PubMed ID: 17720068
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Subtenon Triamcinolone Acetonide Injection with Topical Nepafenac for the Treatment of Pseudophakic Cystoid Macular Edema.
    Yüksel B, Uzunel UD, Kerci SG, Sağban L, Küsbeci T, Örsel T.
    Ocul Immunol Inflamm; 2017 Aug 20; 25(4):513-519. PubMed ID: 27015572
    [Abstract] [Full Text] [Related]

  • 15. PREOPERATIVE VITREORETINAL INTERFACE ABNORMALITIES ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY AS RISK FACTOR FOR PSEUDOPHAKIC CYSTOID MACULAR EDEMA AFTER PHACOEMULSIFICATION.
    Copete S, Martí-Rodrigo P, Muñiz-Vidal R, Pastor-Idoate S, Rigo J, Figueroa MS, García-Arumí J, Zapata MA.
    Retina; 2019 Nov 20; 39(11):2225-2232. PubMed ID: 30157113
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Topical nepafenec in eyes with noncentral diabetic macular edema.
    Friedman SM, Almukhtar TH, Baker CW, Glassman AR, Elman MJ, Bressler NM, Maker MP, Jampol LM, Melia M, Diabetic Retinopathy Clinical Research Network.
    Retina; 2015 May 20; 35(5):944-56. PubMed ID: 25602634
    [Abstract] [Full Text] [Related]

  • 18. Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification.
    Milla E, Stirbu O, Franco IJ, Hernández SJG, Rios J, Duch S.
    Int Ophthalmol; 2017 Oct 20; 37(5):1147-1153. PubMed ID: 27771823
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prophylaxis of macular edema after cataract surgery in diabetic patients, topical Nepafenac versus intravitreal Ranibizumab.
    Howaidy A, Eldaly ZH, Anis M, Othman TM.
    Eur J Ophthalmol; 2022 Jan 20; 32(1):205-212. PubMed ID: 33726537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.